Cerebral toxoplasmosis associated with the use of immunosuppressive treatments by Ivone Melo Valadão, Ana Sofia Sequeira, Vanessa Barcelos

Get full text

Assessment of Lipophilicity Parameters of Antimicrobial and Immunosuppressive Compounds by Dawid Wardecki, Małgorzata Dołowy, Katarzyna Bober-Majnusz

Subjects: Get full text

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia by Yıldız Yıldırmak, Ela Erdem, Leyla Telhan, Laliz Kepekçi

Subjects: “…immunosuppressive treatment…”
Get full text

Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma by Fatih M. Uckun

“…SeverFigurel cellular elements of the bone marrow (BM) microenvironment in multiple myeloma (MM) patients contribute to the immune evasion, proliferation, and drug resistance of MM cells, including myeloid-derived suppressor cells (MDSCs), tumor-associated M2-like, “alternatively activated” macrophages, CD38+ regulatory B-cells (Bregs), and regulatory T-cells (Tregs). These immunosuppressive elements in bidirectional and multi-directional crosstalk with each other inhibit both memory and cytotoxic effector T-cell populations as well as natural killer (NK) cells. …”
Get full text

Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment by Ainhoa Hernández, Marta Domènech, Ana M. Muñoz-Mármol, Cristina Carrato, Carmen Balana

“…In this manuscript, we review how both factors can contribute to an immunosuppressive state and overview the strategies being tested.…”
Get full text

MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer by Christophe Vanhaver, Pierre van der Bruggen, Annika M. Bruger

Subjects: Get full text

Fulminant Adenoviral-Induced Hepatitis in Immunosuppressed Patients by Juliane Kager, Jochen Schneider, Sebastian Rasch, Peter Herhaus, Mareike Verbeek, Carolin Mogler, Albert Heim, Gert Frösner, Dieter Hoffmann, Roland M. Schmid, Tobias Lahmer

Get full text

Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias by Julian Swatler, Laura Turos-Korgul, Ewa Kozlowska, Katarzyna Piwocka

Subjects: Get full text

Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment by Antonia Busse, Liliana H. Mochmann, Christiane Spenke, Ruza Arsenic, Franziska Briest, Korinna Jöhrens, Hedwig Lammert, Bence Sipos, Anja A. Kühl, Ralph Wirtz, Marianne Pavel, Michael Hummel, Daniel Kaemmerer, Richard P. Baum, Patricia Grabowski

“…However, we observed an increased mRNA expression of chemokines, which attract myeloid cells in NET and NEC, and a high abundance of genes related to immunosuppressive myeloid cells and genes with immunosuppressive functions like CD47 and CD74. …”
Get full text

Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine by Ying Wang, Di Gao, Yan Liu, Xiaoqing Guo, Shuojia Chen, Li Zeng, Jinxuan Ma, Xingcai Zhang, Zhongmin Tian, Zhe Yang

“…Significantly, the released PTX and CUR could induce the immunogenic cell death (ICD) to promote adaptive anti-tumor immunogenicity and inhibit immunosuppression through suppressing the activity of indoleamine 2,3-dioxygenase 1 (IDO1) enzyme respectively. …”
Get full text

Edematous pink plaque in a patient on immunosuppression by Mehvish Khan, BS, Hunter J. Pyle, BBA, MD, Travis W. Vandergriff, MD, Cristina Thomas, MD

Get full text

Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment by Yanyu Huang, Hsiao-Chi Wang, Junwei Zhao, Ming-Heng Wu, Tsung-Chieh Shih

“…Galectin-1 (Gal-1), a pivotal immunosuppressive molecule, is expressed by many types of cancer. …”
Get full text

Immunosuppressive Signaling Pathways as Targeted Cancer Therapies by Botle Precious Setlai, Rodney Hull, Meshack Bida, Chrisna Durandt, Thanyani Victor Mulaudzi, Aristotelis Chatziioannou, Zodwa Dlamini

Subjects: “…immunosuppression…”
Get full text

Advances in Immunosuppressive Agents Based on Signal Pathway by Zhiqing Xu, Zhiqing Xu, Ming Chu

Subjects: “…immunosuppressive agent…”
Get full text

Mechanisms of HIF-driven immunosuppression in tumour microenvironment by Shinjini Bandopadhyay, Somi Patranabis

“…This review aims to provide a comprehensive overview of the most crucial mechanisms by which HIF controls the expression of immunosuppressive molecules and immune checkpoints, disrupts cancer immunogenicity, and induces immunotherapeutic resistance.…”
Get full text

Prevention of infection caused by immunosuppressive drugs in gastroenterology by Orlicka, K, Barnes, E, Culver, E

“…Immunosuppressive therapy is frequently used to treat gastrointestinal diseases such as inflammatory bowel disease, autoimmune hepatitis, IgG4-related disease (autoimmune pancreatitis and sclerosing cholangitis) and in the post-transplantation setting. …”

Triple therapy immunosuppression in cadaveric renal transplantation. by Richardson, A, Higgins, R, Ratcliffe, P, Ting, A, Murie, J, Morris, P

“…Thus, triple therapy immunosuppression appears to offer effective immunosuppression, resulting in good graft and patient survival, especially in highly sensitised patients or patients receiving regrafts. …”

THE USE OF MONOCLONAL ANTILYMPHOCYTE ANTIBODIES IN CLINICAL IMMUNOSUPPRESSION by Friend, P, Calne, R, White, D, Hale, G, Waldmann, H

Immunosuppression with monoclonal antibodies--rules for effective serotherapy. by Cobbold, S, Martin, G, Lovat, P, Waldmann, H

Immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies by Raaphorst, J, Gullick, NJ, Pipitone, N, Shokraneh, F, Brassington, R, Ali, SS, Gordon, PA

“…This protocol is for two separate reviews to assess the effects (benefits and harms) of immunosuppressant and immunomodulatory treatments for the idiopathic inflammatory myopathies.…”